← Back to Search

Dopamine Antagonist

Domperidone for Gastroparesis

N/A
Waitlist Available
Led By George L. Arnold, MD
Research Sponsored by Arnold, George, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up domperidone will be prescrided as long as patients benefit from taking it.
Awards & highlights

Study Summary

The purpose of this study is to prescribe oral domperidone for subjects with gastrointestinal disorders who have failed or suffered adverse effects from standard medical treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~domperidone will be prescrided as long as patients benefit from taking it.
This trial's timeline: 3 weeks for screening, Varies for treatment, and domperidone will be prescrided as long as patients benefit from taking it. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement of symptoms for patients with gastrointestinal disorders who have failed or suffered adverse effects from standard medical treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: DomperidoneExperimental Treatment1 Intervention
All eligible subjects will receive domperidone in an open label, single group assignment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Domperidone
FDA approved

Find a Location

Who is running the clinical trial?

Arnold, George, M.D.Lead Sponsor
George L. Arnold, MDPrincipal InvestigatorGeorge L. Arnold, MD, FACP

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Neurogastroenterology and MotilityJournal
Treatment of Gastroparesis: A Multidisciplinary Clinical Review. The American Motility Society Task Force on Gastroparesis (members in Alphabetical Order)
abell, t. l., vr. k. bernstein, t. cutts, g. farrugia, j. forster, w. l. hasler, r. w. mccallum, et al.. 2006. “Treatment of Gastroparesis: A Multidisciplinary Clinical Review. The American Motility Society Task Force on Gastroparesis (members in Alphabetical Order)”. Neurogastroenterology and Motility. Wiley. doi:10.1111/j.1365-2982.2006.00760.x.
clinicaltrials.govStudy
Domperidone for Refractory Gastrointestinal Disorders
George Arnold, MD 2008. "Domperidone for Refractory Gastrointestinal Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00777439.
All > Obsessive Compulsive Disorder
~5 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top